SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021/ PRNewswire/-- United Therapeutics Corporation announced today that it has launched commercial sales of the innovative Remunity ...

Jefferies analyst Eun Yang maintained a Buy rating on United Therapeutics (UTHR - Research Report) on October 20 and set a price target of $260.00. The companys shares opened today at $220.83 ...